Login to Your Account

Pharma: In the clinic

Monday, July 14, 2014
Sanofi SA, of Paris, said its Sanofi Pasteur vaccines division reported that detailed results of its first landmark phase III dengue vaccine efficacy study conducted in five countries in Asia have been published in The Lancet.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription